Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Iplex approved for severe primary IGF-1 deficiency

Dec. 15, 2005

FDA extends Yaz oral contraceptive NDA review period

Dec. 15, 2005

Increlex MAA filed in Europe

Dec. 14, 2005

New candidates for sickle cell disease

Dec. 14, 2005

Novo Nordisk seeks Japanese approval for insulin detemir

Dec. 13, 2005

PSN-9301 effective in reducing glucose levels

Dec. 13, 2005

Treatment begins in phase III study of DX-88 for hereditary angioedema

Dec. 13, 2005

BioDiem to study BDM-E in patients with diabetic macula edema

Dec. 12, 2005

Shire submits MAA for idursulfase for Hunter's syndrome

Dec. 2, 2005

Treatment completed in phase I study of SB-509 in diabetic neuropathy

Dec. 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...